The store will not work correctly when cookies are disabled.
2-(Naphthalen-2-yloxy)-N-tosylacetamide
ID: ALA4482950
PubChem CID: 2142170
Max Phase: Preclinical
Molecular Formula: C19H17NO4S
Molecular Weight: 355.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(S(=O)(=O)NC(=O)COc2ccc3ccccc3c2)cc1
Standard InChI: InChI=1S/C19H17NO4S/c1-14-6-10-18(11-7-14)25(22,23)20-19(21)13-24-17-9-8-15-4-2-3-5-16(15)12-17/h2-12H,13H2,1H3,(H,20,21)
Standard InChI Key: VSMRSWRUYZRWGE-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
21.4987 -8.1843 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9115 -8.8942 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.3199 -8.1818 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7901 -9.3069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4978 -8.8983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2055 -9.3069 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6209 -9.3069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6159 -10.1287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3245 -10.5414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0376 -10.1333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0377 -9.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3285 -8.8993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0824 -8.8983 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3746 -9.3069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6675 -8.8952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6725 -10.5296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3768 -10.1193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9598 -10.1212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9643 -9.3053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2611 -8.8952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5529 -9.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5523 -10.1190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2562 -10.5254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4978 -8.0811 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.7445 -10.5433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 2 1 0
2 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
4 13 1 0
13 14 1 0
14 15 2 0
15 19 1 0
18 16 1 0
16 17 2 0
17 14 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 18 2 0
5 24 2 0
10 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 355.42 | Molecular Weight (Monoisotopic): 355.0878 | AlogP: 3.03 | #Rotatable Bonds: 5 |
Polar Surface Area: 72.47 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.93 | CX Basic pKa: ┄ | CX LogP: 3.59 | CX LogD: 2.65 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.76 | Np Likeness Score: -1.16 |
References
1. Wang P, Luchowska-Stańska U, van Basten B, Chen H, Liu Z, Wiejak J, Whelan P, Morgan D, Lochhead E, Barker G, Rehmann H, Yarwood SJ, Zhou J.. (2020) Synthesis and Biochemical Evaluation of Noncyclic Nucleotide Exchange Proteins Directly Activated by cAMP 1 (EPAC1) Regulators., 63 (10): [PMID:32340447] [10.1021/acs.jmedchem.9b02094] |